Prevalence of Incretin-mimetic and Sodium-Glucose-Transporter-2-Inhibitor Therapy in German Hospitalized Type-2-Diabetics Following Myocardial Revascularization: An Observational Study
posted on 2020-11-11, 10:07authored byRainer U. Pliquett, Linda Golle, Andreas Wienke, Matthias Girndt
Article full
text
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).